Costa Rica’s trans-fat ban impact on cardiovascular disease: a macrosimulation study
Implementing the WHO REPLACE strategy has the potential to substantially reduce CVD mortality, while also improving the population's health and economic productivity. These findings offer strong evidence to advocate for regulatory actions in Costa Rica and other nations across the Americas region to eliminate IP-TFAs from the food supply.
Authors
- Rafael Monge‐Rojas (ORCID: https://orcid.org/0000-0001-7660-2508)
- Victor E Villalobos-Daniel (ORCID: https://orcid.org/0000-0003-1112-8643)
- Eduardo Augusto Fernandes Nilson (ORCID: https://orcid.org/0000-0002-2650-4878)
- Rulamán Vargas-Quesada (ORCID: https://orcid.org/0000-0002-5944-3071)
Institutions
- Instituto Tecnológico de Costa Rica (CR)
- World Health Organization Regional Office for the Americas (US)
- Fundação Oswaldo Cruz (BR)
- Sage (United Kingdom) (GB)
Publication Details
- Journal
- Revista Panamericana de Salud Pública
- Published
- 2025-10-10
- DOI
- https://doi.org/10.26633/rpsp.2025.97
- Primary Topic
- Fatty Acid Research and Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00